Clinical trial
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
NCT03578354 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 31, 2019
- Completion date
- August 31, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.